Filing Details
- Accession Number:
- 0001203311-23-000123
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-13 20:02:01
- Reporting Period:
- 2023-11-10
- Accepted Time:
- 2023-11-13 20:02:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1445826 | R David Epstein | 21823 30Th Drive Se Bothell WA 98021 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-10 | 10,620 | $213.01 | 136,598 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a written agreement governing the terms of restricted stock units granted to the reporting person, which includes a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) to satisfy tax obligations arising out of the vesting of such stock units (the "Sell-to-Cover Trading Arrangement"). The written agreement, adopted December 14, 2022, provides that, if the filer is in possession of material, nonpublic information as of the date of grant of such stock units, then the Sell-to-Cover Trading Arrangement becomes a binding contract as of the first date thereafter on which the filer is not in possession of material, nonpublic information.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.